Skip to content

GlobalLawDBby GenieAI

Laws Search Sanctions Map Data Developers

Search the text of the law

Log in Get an API key

Laws Search Sanctions Map Data Developers

Log in Get an API key

The Global Law Database. Free to read, built for people and AI agents.

Explore

All laws
Search the text
Sanctions
Map of connections
Compare UK and EU

Developers

AI agents (MCP)
REST API
Bulk data
API keys

Coverage

United Kingdom
European Union
United States
Canada
Australia
France
Germany
Netherlands
Spain
Austria
Norway
Finland
Switzerland
Ireland

GlobalLawDB is made by GenieAI, London. It is not legal advice: check the official text before relying on it. Text comes from official publishers under their licences, listed on the Data page.

ThemeMatch my systemLightDark

European Union
Dr. August Wolff GmbH & Co. KG Arzneimittel and Remedia d.o.o. v European Commission (C-680/16 P)
The appeal
Findings of the Court
30

Dr. August Wolff GmbH & Co. KG Arzneimittel and Remedia d.o.o. v European Commission (C-680/16 P)

Judgment of 27 Mar 2019law://eu/cjeu/2016/c-680-16/para_30@2026-11-10

30As the appellants have submitted, the objective impartiality of the Committee may be jeopardised where one of its members could have a conflict of interest as the result of an overlap in function, irrespective of that member’s actual conduct.

Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.

Key facts

Court: Court of Justice · Fourth Chamber
Case: C-680/16 P · ECLI:EU:C:2019:257
Decided: 27 Mar 2019
Procedure: Action for annulment
Ruled invalid: 62014TJ0672
Applicants: Dr. August Wolff GmbH & Co. KG Arzneimittel; Remedia d.o.o
Defendant: European Commission
Rapporteur: E. Juhász
Advocate General: P. Mengozzi
Bench: 5 judges
T. von Danwitz, K. Jürimäe, C. Lycourgos, E. Juhász, C. Vajda
Language: German
Official: CURIA · EUR-Lex 62016CJ0680

Topics

History · 1 version

27 Mar 2019Reading

Connections

Interprets 1: Dr. August Wolff GmbH & Co. KG Arzneimittel and Remedia d.o.o. v European Commission (T-672/14)
Cited by 23: UF v European Parliament (T-1137/23); DP and DQ v European Insurance and Occupational Pensions Authority (T-183/24); Lantmännen ek för and Lantmännen Biorefineries AB v European Commission (T-93/24); Sanofi BV, anciennement Genzyme Europe BV v European Commission (T-483/22); XH v European Commission (T-1083/23); TT v European Border and Coast Guard Agency (T-787/22); Jean-Marc Colombani v European External Action Service (T-158/23); International Management Group (IMG) v European Commission (T-509/21); PV v European Commission (T-89/20); Hanns Pfriem v European Union Intellectual Property Office (T-316/23); Danske Slagtermestre v European Commission (T-486/18 R)2 provisions; Debregeas et associés Pharma (D & A Pharma) v European Commission and European Medicines Agency (C-291/22 P)2 provisions; Crédit agricole SA and Crédit agricole Corporate and Investment Bank v European Commission (T-113/17); Laura Molina Fernández v Single Resolution Board (T-304/20); YD v European Union Agency for Fundamental Rights (T-648/21); Carles Puigdemont i Casamajó and Others v European Parliament (T-272/21); UPL Europe Ltd and Indofil Industries (Netherlands) BV v European Commission (T-742/20); HSBC Holdings plc and Others v European Commission (C-883/19 P); JS v Single Resolution Board (T-270/20); Ángel Vasallo Andrés v European Parliament (T-496/21); DD v European Union Agency for Fundamental Rights (T-470/20); Debregeas et associés Pharma (D & A Pharma) v European Commission and European Medicines Agency (T-556/20); JR v European Commission (T-265/20)
Cites 7: Charter of Fundamental Rights of the European Union (consolidated 2016); Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use; Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance); Ziegler SA v European Commission (C-439/11 P); Kingdom of Spain v Council of the European Union (C-521/15); Ermioni Komninou and Others v Commission of the European Communities (C-167/06); Dr. August Wolff GmbH & Co. KG Arzneimittel and Remedia d.o.o. v European Commission (T-672/14)